- Home
- RYTM vs ENLT Comparison
RYTM vs ENLT Comparison
Compare RYTM & ENLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RYTM | ENLT |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.4B |
| IPO Year | 2017 | 2023 |
Fundamental Metrics
Financial Performance| Metric | RYTM | ENLT |
|---|---|---|
| Price | $111.98 | $42.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $127.31 | $37.50 |
| AVG Volume (30 Days) | ★ 966.4K | 30.3K |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 132.72 |
| EPS | N/A | ★ 0.96 |
| Revenue | $174,334,000.00 | ★ $457,756,000.00 |
| Revenue This Year | $47.34 | $355.90 |
| Revenue Next Year | $57.18 | $42.83 |
| P/E Ratio | ★ N/A | $42.93 |
| Revenue Growth | ★ 54.92 | 27.72 |
| 52 Week Low | $45.91 | $14.01 |
| 52 Week High | $122.20 | $42.38 |
Technical Indicators
Market Signals| Indicator | RYTM | ENLT |
|---|---|---|
| Relative Strength Index (RSI) | 57.05 | 63.26 |
| Support Level | $109.99 | $38.48 |
| Resistance Level | $115.05 | $40.03 |
| Average True Range (ATR) | 5.20 | 1.09 |
| MACD | 0.60 | -0.08 |
| Stochastic Oscillator | 53.93 | 88.72 |
Price Performance
Historical ComparisonAbout RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About ENLT Enlight Renewable Energy Ltd.
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, which produces its revenue from the sale of the electricity that is produced through wind energy and solar energy in Europe.